RECRUITING

Project Dulce for Arab-Americans With Type 2 Diabetes

Talk to us

Conditions

Diabetes Mellitus, Type 2Diabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arabic) is adapted from the Project Dulce, an American Diabetes Association (ADA)-recognized Diabetes Self-Management Education Support (DSMES) program. Project Dulce Arabic comprises both peer-led diabetes education in Arabic and a 3-month text messaging program (Dulce Digital). The main aim of the study is to examine the effectiveness of a more culturally and linguistically appropriate diabetes education program in improving diabetes knowledge, beliefs, and self-management as well as hemoglobin A1C.

Official Title

Project Dulce for Arab-Americans With Type 2 Diabetes

Quick Facts

Study Start:2023-02-17
Study Completion:2025-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05580536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identified Arab
  2. * Diagnosed with type 2 diabetes mellitus (T2DM)
  3. * Registered in the community clinic (or willing to register)
  4. * HbA1c ≥8% within 1 month of screening
  5. * Able to speak, read, write, and comprehend in English and Arabic
  1. * Severe illness precluding frequent visits to clinic
  2. * Liver function tests (ALT and AST) \> 3 times the upper limit of normal
  3. * Body mass index ≤ 23 kg/cm
  4. * History of malignancy, except subjects who have been disease-free for \> 5 years, or whose only malignancy has been basal or squamous cell skin carcinoma
  5. * Creatinine \> 3.5
  6. * History of drug or alcohol abuse within 12 months prior to enrollment
  7. * Not a permanent resident in the area
  8. * Current enrollee in Project Dulce
  9. * Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening
  10. * Anemia
  11. * Primary language other than English or Arabic
  12. * Not willing to carry a mobile phone
  13. * Type 1 or gestational diabetes
  14. * Pregnant

Contacts and Locations

Study Contact

Ahmed Khattab, MD
CONTACT
8586787049
akhattab@scripps.edu

Principal Investigator

Ahmed Khattab, MD
PRINCIPAL_INVESTIGATOR
Scripps

Study Locations (Sites)

San Ysidro Health
El Cajon, California, 92020
United States

Collaborators and Investigators

Sponsor: Scripps Whittier Diabetes Institute

  • Ahmed Khattab, MD, PRINCIPAL_INVESTIGATOR, Scripps

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-17
Study Completion Date2025-02

Study Record Updates

Study Start Date2023-02-17
Study Completion Date2025-02

Terms related to this study

Keywords Provided by Researchers

  • Diabetes

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2